BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raqib R, Wretlind B, Andersson J, Lindberg AA. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis. 1995;171:376-384. [PMID: 7531208 DOI: 10.1093/infdis/171.2.376] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Bagchi AK, Sinha AK, Adhikari R, Maiti P, Mukherjee J, Panda A, Saha DR. Selective Deletion of CD8+ Cells Upregulated by Caspases-1 via IL-18 in Mice Immunized with Major Outer Membrane Protein of Shigella dysenteriae 1 Following Infection. J Clin Immunol 2010;30:408-18. [DOI: 10.1007/s10875-009-9359-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Svennerholm A, Steele D. Progress in enteric vaccine development. Best Practice & Research Clinical Gastroenterology 2004;18:421-45. [DOI: 10.1016/j.bpg.2003.11.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
3 Raqib R, Lindberg AA, Björk L, Bardhan PK, Wretlind B, Andersson U, Andersson J. Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection. Infect Immun 1995;63:3079-87. [PMID: 7622234 DOI: 10.1128/iai.63.8.3079-3087.1995] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yuhas Y, Weizman A, Vanichkin A, Ashkenazi S. Involvement of prostaglandins in an animal model of Shigella-related seizures. Journal of Neuroimmunology 2005;168:34-9. [DOI: 10.1016/j.jneuroim.2005.06.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Raqib R, Wretlind B, Lindberg AA, Ljungdahl A, Andersson J. Pathogenesis and immune responses in shigellosis. Ann N Y Acad Sci 1996;797:299-301. [PMID: 8993387 DOI: 10.1111/j.1749-6632.1996.tb52985.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
6 Weinstein DL, O'neill BL, Metcalf ES. Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6. Infect Immun 1997;65:395-404. [DOI: 10.1128/iai.65.2.395-404.1997] [Cited by in Crossref: 53] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
7 Proulx F, Litalien C, Turgeon JP, Mariscalco MM, Seidman E. Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome. Am J Kidney Dis 2000;35:29-34. [PMID: 10620540 DOI: 10.1016/s0272-6386(00)70297-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
8 Yuhas Y, Weizman A, Chrousos GP, Ovadia H, Ashkenazi S. Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures. Journal of Neuroimmunology 2004;153:36-9. [DOI: 10.1016/j.jneuroim.2004.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
9 Sinha AK, Bagchi AK. Role of anti-CD3 in modulation of Th1-type immune response in Shigella dysenteriae infection. J Med Microbiol 2004;53:1075-81. [PMID: 15496383 DOI: 10.1099/jmm.0.05420-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Pál T, Lindberg AA. Oral Vaccines for Shigella. Mucosal Vaccines. Elsevier; 1996. pp. 213-28. [DOI: 10.1016/b978-012410580-5/50017-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
11 Brigotti M, Carnicelli D, Arfilli V, Porcellini E, Galassi E, Valerii MC, Spisni E. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome. Int J Med Microbiol 2018;308:940-6. [PMID: 29983334 DOI: 10.1016/j.ijmm.2018.06.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
12 Yuhas Y, Weizman A, Ashkenazi S. Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures. Infect Immun 2003;71:2288-91. [PMID: 12654859 DOI: 10.1128/IAI.71.4.2288-2291.2003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
13 Fernandez MI, Sansonetti PJ. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis. International Journal of Medical Microbiology 2003;293:55-67. [DOI: 10.1078/1438-4221-00244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
14 Azim T, Sarker MS, Hamadani J, Khanum N, Halder RC, Salam MA, Albert MJ. Alterations in lymphocyte phenotype and function in children with shigellosis who develop complications. Clin Diagn Lab Immunol 1996;3:191-6. [PMID: 8991634 DOI: 10.1128/cdli.3.2.191-196.1996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Isabel Fernandez M, Sansonetti PJ. Effector Molecules of Shigella Pathogenesis and Host Responses. In: Hecht GA, editor. Microbial Pathogenesis and the Intestinal Epithelial Cell. Washington: ASM Press; 2003. pp. 455-79. [DOI: 10.1128/9781555817848.ch25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Sansonetti P, Phalipon A. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development. Res Immunol 1996;147:595-602. [PMID: 9127893 DOI: 10.1016/s0923-2494(97)85227-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
17 Baeshen HA. Assessment of salivary pro inflammatory cytokines profile level in patients treated with labial and lingual fixed orthodontic appliances. PLoS One 2021;16:e0249999. [PMID: 33886621 DOI: 10.1371/journal.pone.0249999] [Reference Citation Analysis]
18 Raqib R, Qadri F, Sarker P, Mia SMS, Sansonnetti PJ, Albert MJ, Andersson J. Delayed and Reduced Adaptive Humoral Immune Responses in Children with Shigellosis Compared with in Adults: Reduced Specific Immunity in Children with Shigellosis. Scandinavian Journal of Immunology 2002;55:414-23. [DOI: 10.1046/j.1365-3083.2002.01079.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
19 de Jong MF, Alto NM. Thinking outside the Osp(G)--kinase activation by E2-ubiquitin. EMBO J 2014;33:403-4. [PMID: 24480478 DOI: 10.1002/embj.201387606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Dupont HL. Shigella Species (Bacillary Dysentery). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2905-10. [DOI: 10.1016/b978-0-443-06839-3.00224-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
21 Marteyn B, Gazi A, Sansonetti P. Shigella: a model of virulence regulation in vivo. Gut Microbes 2012;3:104-20. [PMID: 22356862 DOI: 10.4161/gmic.19325] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 6.2] [Reference Citation Analysis]
22 Chen CC, Chang CJ, Lin TY, Lai MW, Chao HC, Kong MS. Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea. World J Gastroenterol 2011; 17(37): 4218-4224 [PMID: 22072854 DOI: 10.3748/wjg.v17.i37.4218] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
23 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB. A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. PLoS One 2018;13:e0189571. [PMID: 29304144 DOI: 10.1371/journal.pone.0189571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007;5:540-53. [PMID: 17558427 DOI: 10.1038/nrmicro1662] [Cited by in Crossref: 235] [Cited by in F6Publishing: 207] [Article Influence: 16.8] [Reference Citation Analysis]
25 Kuehl CJ, D'Gama JD, Warr AR, Waldor MK. An Oral Inoculation Infant Rabbit Model for Shigella Infection. mBio 2020;11:e03105-19. [PMID: 31964739 DOI: 10.1128/mBio.03105-19] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Calabrese EJ. Modulation of the Epileptic Seizure Threshold: Implications of Biphasic Dose Responses. Critical Reviews in Toxicology 2008;38:543-56. [DOI: 10.1080/10408440802014261] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
27 Saiki T, Mitsuyama K, Toyonaga A, Ishida H, Tanikawa K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol. 1998;33:616-622. [PMID: 9669634 DOI: 10.1080/00365529850171891] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.1] [Reference Citation Analysis]
28 King AJ. Acute inflammation in the pathogenesis of hemolytic-uremic syndrome. Kidney International 2002;61:1553-64. [DOI: 10.1046/j.1523-1755.2002.00281.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Mcghee JR, Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. Interleukin-8 Controls Bacterial Transepithelial Translocation at the Cost of Epithelial Destruction in Experimental Shigellosis. Infect Immun 1999;67:1471-80. [DOI: 10.1128/iai.67.3.1471-1480.1999] [Cited by in Crossref: 163] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
30 Raqib R, Ekberg C, Sharkar P, Bardhan PK, Zychlinsky A, Sansonetti PJ, Andersson J. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect Immun 2002;70:3199-207. [PMID: 12011015 DOI: 10.1128/IAI.70.6.3199-3207.2002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
31 Islam D, Ruamsap N, Khantapura P, Aksomboon A, Srijan A, Wongstitwilairoong B, Bodhidatta L, Gettayacamin M, Venkatesan MM, Mason CJ. Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations. APMIS 2014;122:463-75. [PMID: 24028276 DOI: 10.1111/apm.12168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Turbyfill KR, Mertz JA, Mallett CP, Oaks EV. Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD). Infect Immun 1998;66:1999-2006. [PMID: 9573082 DOI: 10.1128/IAI.66.5.1999-2006.1998] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
33 Stoycheva M, Murdjeva M. Correlation between Serum Levels of Interleukin-1β, Interleukin- 1RA, Interleukin-6, Interleukin-10, Interleukin 12, Tumor Necrosis Factor-α and Interferon-γ with some Clinical and Laboratory Parameters in Patients with Salmonellosis. Biotechnology & Biotechnological Equipment 2014;19:143-6. [DOI: 10.1080/13102818.2005.10817170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000;19:642-7. [PMID: 10917223 DOI: 10.1097/00006454-200007000-00012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
35 Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J 1998;17:899-904. [PMID: 9802632 DOI: 10.1097/00006454-199810000-00010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
36 Raja SB, Murali MR, Devaraj H, Devaraj SN. Differential expression of gastric MUC5AC in colonic epithelial cells: TFF3-wired IL1 β/Akt crosstalk-induced mucosal immune response against Shigella dysenteriae infection. Journal of Cell Science 2012;125:703-13. [DOI: 10.1242/jcs.092148] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
37 Raqib R, Sarker P, Mily A, Alam NH, Arifuzzaman AS, Rekha RS, Andersson J, Gudmundsson GH, Cravioto A, Agerberth B. Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infect Dis. 2012;12:111. [PMID: 22574737 DOI: 10.1186/1471-2334-12-111] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
38 Islam D, Wretlind B, Hammarström L, Christensson B, Lindberg AA. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis. APMIS 1996;104:563-74. [PMID: 8920810 DOI: 10.1111/j.1699-0463.1996.tb04912.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
39 Keusch GT, Acheson DWK. Shigella Infection. In: Paradise LJ, Bendinelli M, Friedman H, editors. Enteric Infections and Immunity. Boston: Springer US; 1996. pp. 79-100. [DOI: 10.1007/978-1-4899-0313-6_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 2003;5:481-91. [DOI: 10.1046/j.1462-5822.2003.00295.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
41 Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun 1997;65:739-49. [PMID: 9009337 DOI: 10.1128/iai.65.2.739-749.1997] [Cited by in Crossref: 75] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
42 Yuhas Y, Shulman L, Weizman A, Kaminsky E, Vanichkin A, Ashkenazi S. Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect Immun 1999;67:1455-60. [PMID: 10024595 DOI: 10.1128/IAI.67.3.1455-1460.1999] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
43 Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis. J Clin Pathol 1997;50:513-20. [PMID: 9378821 DOI: 10.1136/jcp.50.6.513] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
44 Hester SN, Mastaloudis A, Gray R, Antony JM, Evans M, Wood SM. Efficacy of an Anthocyanin and Prebiotic Blend on Intestinal Environment in Obese Male and Female Subjects. J Nutr Metab 2018;2018:7497260. [PMID: 30302287 DOI: 10.1155/2018/7497260] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
45 Lee MS, Koo S, Jeong DG, Tesh VL. Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications. Toxins (Basel) 2016;8:E77. [PMID: 26999205 DOI: 10.3390/toxins8030077] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 10.6] [Reference Citation Analysis]
46 Ashkenazi S. Shigella infections in children: new insights. Semin Pediatr Infect Dis 2004;15:246-52. [PMID: 15494948 DOI: 10.1053/j.spid.2004.07.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
47 Kotloff KL, Noriega F, Losonsky GA, Sztein MB, Wasserman SS, Nataro JP, Levine MM. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun 1996;64:4542-8. [DOI: 10.1128/iai.64.11.4542-4548.1996] [Cited by in Crossref: 82] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
48 Duménil G, Olivo JC, Pellegrini S, Fellous M, Sansonetti PJ, Nhieu GT. Interferon alpha inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J Cell Biol 1998;143:1003-12. [PMID: 9817757 DOI: 10.1083/jcb.143.4.1003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
49 Mcghee JR, Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DWK. Shiga Toxins Stimulate Secretion of Interleukin-8 from Intestinal Epithelial Cells. Infect Immun 1999;67:5985-93. [DOI: 10.1128/iai.67.11.5985-5993.1999] [Cited by in Crossref: 140] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
50 Raqib R, Ljungdahl A, Lindberg AA, Andersson U, Andersson J. Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection. Gut 1996;38:328-36. [PMID: 8675083 DOI: 10.1136/gut.38.3.328] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
51 Raqib R, Roy SK, Rahman MJ, Azim T, Ameer SS, Chisti J, Andersson J. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. The American Journal of Clinical Nutrition 2004;79:444-50. [DOI: 10.1093/ajcn/79.3.444] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
52 Phalipon A, Sansonetti PJ. Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites. Curr Top Microbiol Immunol. 1999;236:163-189. [PMID: 9893360 DOI: 10.1007/978-3-642-59951-4_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
53 Q S Medeiros PH, Ledwaba SE, Bolick DT, Giallourou N, Yum LK, Costa DVS, Oriá RB, Barry EM, Swann JR, Lima AÂM, Agaisse H, Guerrant RL. A murine model of diarrhea, growth impairment and metabolic disturbances with Shigella flexneri infection and the role of zinc deficiency. Gut Microbes 2019;10:615-30. [PMID: 30712505 DOI: 10.1080/19490976.2018.1564430] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
54 Islam D, Wretlind B, Lindberg AA, Christensson B. Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis. Infect Immun 1996;64:1391-9. [DOI: 10.1128/iai.64.4.1391-1399.1996] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
55 Bhutta ZA. Effect of infections and environmental factors on growth and nutritional status in developing countries. J Pediatr Gastroenterol Nutr 2006;43 Suppl 3:S13-21. [PMID: 17204974 DOI: 10.1097/01.mpg.0000255846.77034.ed] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
56 Steiner TS, Flores CA, Pizarro TT, Guerrant RL. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 1997;4:719-22. [DOI: 10.1128/cdli.4.6.719-722.1997] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
57 Phalipon A, Sansonetti PJ. Shigella’ s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 2007;85:119-29. [DOI: 10.1038/sj.icb7100025] [Cited by in Crossref: 161] [Cited by in F6Publishing: 142] [Article Influence: 11.5] [Reference Citation Analysis]
58 Hathaway LJ, Griffin GE, Sansonetti PJ, Edgeworth JD. Human monocytes kill Shigella flexneri but then die by apoptosis associated with suppression of proinflammatory cytokine production. Infect Immun 2002;70:3833-42. [PMID: 12065527 DOI: 10.1128/IAI.70.7.3833-3842.2002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
59 Hermansson AK, Paciello I, Bernardini ML. The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms. Curr Top Microbiol Immunol 2016;397:91-115. [PMID: 27460806 DOI: 10.1007/978-3-319-41171-2_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
60 Long KZ, Estrada-Garcia T, Rosado JL, Ignacio Santos J, Haas M, Firestone M, Bhagwat J, Young C, DuPont HL, Hertzmark E, Nanthakumar NN. The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea. J Nutr 2006;136:1365-70. [PMID: 16614431 DOI: 10.1093/jn/136.5.1365] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
61 Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:164-71. [PMID: 8856584 DOI: 10.1097/00005176-199608000-00012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
62 Raqib R, Mia SM, Qadri F, Alam TI, Alam NH, Chowdhury AK, Mathan MM, Andersson J. Innate immune responses in children and adults with Shigellosis. Infect Immun 2000;68:3620-9. [PMID: 10816520 DOI: 10.1128/IAI.68.6.3620-3629.2000] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
63 Raqib R, Gustafsson A, Andersson J, Bakhiet M. A systemic downregulation of gamma interferon production is associated with acute shigellosis. Infect Immun 1997;65:5338-41. [DOI: 10.1128/iai.65.12.5338-5341.1997] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
64 de Jong MF, Liu Z, Chen D, Alto NM. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation. Nat Microbiol 2016;1:16084. [PMID: 27572974 DOI: 10.1038/nmicrobiol.2016.84] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
65 Peng​ W, Lu D, Li G, Zhang X, Yao M, Zhang Y, Lin H. Two distinct interferon-γ genes in Tetraodon nigroviridis : Functional analysis during Vibrio parahaemolyticus infection. Molecular Immunology 2016;70:34-46. [DOI: 10.1016/j.molimm.2015.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
66 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB, Levy D. Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics. PLoS One 2013;8:e59465. [PMID: 23589755 DOI: 10.1371/journal.pone.0059465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Raqib R, Ljungdahl Å, Lindberg AA, Wretlind B, Andersson U, Andersson J. Dissociation between cytokine mRNA expression and protein production in shigellosis. Eur J Immunol 1996;26:1130-8. [DOI: 10.1002/eji.1830260526] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
68 de Jong MF, Alto NM. Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins. Infect Immun 2018;86:e00560-17. [PMID: 29339461 DOI: 10.1128/IAI.00560-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Enocksson A, Lundberg J, Weitzberg E, Norrby-Teglund A, Svenungsson B. Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis. Clin Diagn Lab Immunol 2004;11:250-4. [PMID: 15013971 DOI: 10.1128/cdli.11.2.250-254.2004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
70 Degré M. Interferons and other cytokines in bacterial infections. J Interferon Cytokine Res 1996;16:417-26. [PMID: 8807494 DOI: 10.1089/jir.1996.16.417] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
71 Sansonetti PJ, Egile C, Wennerås C. Shigellosis: From Disease Symptoms to Molecular and Cellular Pathogenesis. Principles of Bacterial Pathogenesis. Elsevier; 2001. pp. 335-85. [DOI: 10.1016/b978-012304220-0/50009-1] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
72 Rahman MJ, Sarker P, Roy SK, Ahmad SM, Chisti J, Azim T, Mathan M, Sack D, Andersson J, Raqib R. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. The American Journal of Clinical Nutrition 2005;81:495-502. [DOI: 10.1093/ajcn.81.2.495] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
73 Samandari T, Kotloff KL, Losonsky GA, Picking WD, Sansonetti PJ, Levine MM, Sztein MB. Production of IFN-γ and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 Strain. J Immunol 2000;164:2221-32. [DOI: 10.4049/jimmunol.164.4.2221] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
74 Pore D, Mahata N, Pal A, Chakrabarti MK. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One 2011;6:e22663. [PMID: 21818362 DOI: 10.1371/journal.pone.0022663] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
75 Raqib R, Moly PK, Sarker P, Qadri F, Alam NH, Mathan M, Andersson J. Persistence of mucosal mast cells and eosinophils in Shigella-infected children. Infect Immun 2003;71:2684-92. [PMID: 12704143 DOI: 10.1128/IAI.71.5.2684-2692.2003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
76 Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev 2011;239:125-48. [PMID: 21198669 DOI: 10.1111/j.1600-065X.2010.00970.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 83] [Article Influence: 16.5] [Reference Citation Analysis]
77 Fernandez-Prada CM, Hoover DL, Tall BD, Venkatesan MM. Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis. Infect Immun 1997;65:1486-96. [PMID: 9119491 DOI: 10.1128/iai.65.4.1486-1496.1997] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
78 Bagchi AK, Sinha AK. Role of 57 kDa major antigenic component of Shigella dysenteriae outer membrane proteins in induction of major histocompatibility complex II-restricted T-cell response. Archives of Medical Research 2004;35:427-34. [DOI: 10.1016/j.arcmed.2004.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]